Pharmacists and GPs to work more closely

NHS England will be looking to see that these pharmacists are suitably trained and this will include working towards or already being an Independent prescriber.   

Click on the links below to read the announcement from NHS England:-

http://www.england.nhs.uk/2015/07/07/pharm-supp-gp-surgeries/

 http://www.england.nhs.uk/commissioning/primary-care-comm/gp-action-plan/cp-gp-pilot/

Latest News from Scotland:

The Scottish NHS Health Boards and the Scottish Government have demonstrated a significant and sustained commitment to supporting Non Medical Prescribing (NMP) through the implementation of the Scottish strategy for NMP, ‘A Safe Prescription’.
In Scotland NMP implementation and development is led nationally by the Scottish Nursing Midwifery and Allied Health Professional (NMAHP) Prescribing Leads Group. The group has representation from each of the Scottish Health Boards, Special Boards, Universities, Advisory bodies and Scottish Government. The current Chair and Co-Chair of the group are Gavin Gorman and Andrew Rideout (Also AfP committee members).
The group sponsor an annual national conference held in May, and individual health boards run local conferences and events, some of which are opened up to other neighbouring health boards to attend.
NHS Education for Scotland (NES) provides a valuable role in supporting NMP’s working in Scotland and details/information can be accessed via their website. (Link)
There is also a Scotland wide network made up of course leaders from each of the universities that offer the NMP modules. The network is represented on the Scottish NMAHP Prescribing Leads Group and function to ensure consistency in the modules offered by different institutions, meet the demand for training required by the health boards, expand research on NMP, support the ongoing implementation of NMP, and meet the needs of new professional groups requiring training.
For any further information or enquiries about Non Medical Prescribing in Scotland please contact Gavin Gorman/Andrew Rideout via the AfP Committee or alternatively enquiries can be made directly to Ian Roxburgh (Scottish Government Policy Officer and group admin) ian.roxburgh@scotland.gsi.gov.uk

Links
NHS Education for Scotland (NES) NMP Page
Scottish Medicines Consortium
A Safe Prescription
Prescription for Excellence
Scottish Patient Safety Programme
Scottish Government NMP Page
National Substance Misuse NMP Forum Scotland
Scottish Antimicrobial Prescribing Group (SAPG)
Healthcare Improvement Scotland
NHS Greater Glasgow and Clyde Medicines site
Edinburgh Napier University
Glasgow Caledonian University
University of the West of Scotland
University of Stirling
University of Dundee
Robert Gordon University

NMC and GMC Working Together

We are pleased to share with you guidance for doctors, nurses and midwives on the professional duty of candour, which the Nursing and Midwifery Council (NMC) and the General Medical Council (GMC) have produced jointly.

Good medical practice and the Code for nurses and midwives make it clear that doctors, nurses and midwives have a professional duty, the duty of candour, to be open and honest with patients when things go wrong. They should always report when mistakes are made that have compromised – or could have compromised – patient safety.

This guidance will reinforce this shared professional duty. It will also give a framework and confidence to individuals working with patients to respond openly and honestly when things go wrong.

The guidance will be helpful for all individuals, groups and organisations across the UK working to establish a much more transparent and open culture. For example, it will help:

  • employers of doctors, nurses and midwives in understanding what the professional obligations are in being open and honest;
  • unions and professional bodies in helping to support doctors, nurses and midwives who want more information about how to raise a concern;
  • charities and advocacy services supporting patients, in empowering patients to know what transparency they are entitled to;
  • doctors, nurses and midwives in knowing what their professional duty is and having the confidence to act on it;
  • educators of doctors, nurses and midwives in informing their training and development programmes, and;
  • other organisations in understanding the requirements and implications of the duty of candour.

The guidance is available to read and download via the GMC website and the NMC website.

Support for GP’s

The Royal Collage of GPs is “looking to regulators to support GPs who refused to prescribe unnecessary antibiotics and then faced complaints from patients”

So what does NICE itself have to say? It points out that: “Antibiotics have dramatically reduced the number of deaths from infections and infectious diseases since they were introduced 70 years ago. They are now a vital tool for modern medicine and not just for the treatment of infections, such as pneumonia, meningitis and tuberculosis, but also for preventing infections from occurring during surgical procedures and cancer treatment.”

The down side is “Our antibiotic resistance problem is compounded by the fact that the discovery of new antibiotics is at an all-time low, even though we’ve always had an understanding of the problems we could face if we run out of effective antibiotics.”

NICE has advice for improving the present situation, “Our guidance on the prescribing of antibiotics for respiratory tract infections, an area where antibiotics are often over prescribed, can play an important role in reducing inappropriate prescribing. Healthcare professionals should reassure patients that antibiotics will make little difference to symptoms, and may have side effects such as diarrhoea, vomiting and rash.”

The cause of all the heart searching is that, despite the prophesies of doom, broad spectrum antibiotic prescribing has gone up whilst it has been 30 years since a new class of antibiotics was last introduced. Drug companies are most interested in chronic diseases – ones that require patients to take medication for years. Conditions such as raised blood pressure, raised cholesterol and asthma are, therefore, attractive – that’s where the big profits are to be found. To invest the £billions it takes to bring a new drug to the marketplace knowing that the target population is only likely to take it for a few days is not good business.

In addition to ‘doctor bashing’ NICE is going to turn its attention to the patients who it says ‘demand antibiotics inappropriately’. Advice on ‘antimicrobial stewardship’ will be issued to ‘the general population’ in due course.

Leave a Reply